SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CORALLINI, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.075
AS - Asia 1.582
EU - Europa 806
SA - Sud America 226
AF - Africa 26
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.722
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.018
SG - Singapore 663
CN - Cina 537
BR - Brasile 201
UA - Ucraina 187
DE - Germania 156
GB - Regno Unito 132
HK - Hong Kong 125
IT - Italia 120
TR - Turchia 115
VN - Vietnam 62
FI - Finlandia 56
SE - Svezia 39
CA - Canada 38
RU - Federazione Russa 33
PL - Polonia 22
IN - India 19
FR - Francia 17
ZA - Sudafrica 17
AR - Argentina 15
MX - Messico 14
CZ - Repubblica Ceca 10
ES - Italia 8
BD - Bangladesh 7
ID - Indonesia 7
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
AU - Australia 5
BE - Belgio 5
IR - Iran 5
JP - Giappone 5
NL - Olanda 5
IL - Israele 4
UZ - Uzbekistan 4
CO - Colombia 3
NP - Nepal 3
PK - Pakistan 3
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
MD - Moldavia 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
EE - Estonia 1
EU - Europa 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 6.722
Salva come PNG Salva come JPEG
Città #
Fairfield 492
Woodbridge 464
Ashburn 385
Singapore 334
Houston 266
Seattle 218
Chandler 211
Jacksonville 208
Ann Arbor 195
Cambridge 178
Wilmington 160
Beijing 158
Santa Clara 150
Hong Kong 125
Los Angeles 83
New York 79
Dallas 77
Nanjing 68
Izmir 63
Princeton 46
Munich 36
Boardman 34
San Diego 34
Milan 30
Shanghai 26
Ho Chi Minh City 25
Shenyang 25
Nanchang 23
São Paulo 23
Buffalo 20
Warsaw 18
Ferrara 17
Tianjin 15
Changsha 14
Falls Church 13
Jinan 13
Montreal 13
San Mateo 13
Hanoi 12
Johannesburg 12
The Dalles 12
Turku 12
Auburn Hills 11
Hebei 11
London 11
Mountain View 11
Poplar 11
Zhengzhou 11
Chennai 10
Chicago 10
Frankfurt am Main 10
Mexico City 10
Orem 10
San Francisco 10
Hefei 9
Dearborn 8
Falkenstein 8
Stockholm 8
Atlanta 7
Bremen 7
Brno 7
Philadelphia 7
Toronto 7
Boston 6
Brasília 6
Brooklyn 6
Columbus 6
Haikou 6
Manchester 6
Moscow 6
Ottawa 6
Redwood City 6
Rome 6
Brussels 5
Charlotte 5
Denver 5
Kunming 5
Norwalk 5
Porto Alegre 5
Tappahannock 5
Tokyo 5
Ardabil 4
Curitiba 4
Guarulhos 4
Hangzhou 4
Leawood 4
Phoenix 4
Rio de Janeiro 4
Vancouver 4
Ankara 3
Augusta 3
Bologna 3
Changchun 3
Da Nang 3
Des Moines 3
Guangzhou 3
Haiphong 3
Helsinki 3
Jakarta 3
Jiaxing 3
Totale 4.759
Salva come PNG Salva come JPEG
Nome #
Antiangiogenic activity of the MDM2 antagonist nutlin-3 217
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 209
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 205
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 203
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies 194
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 194
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 190
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 188
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 185
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 182
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 180
Is there any role for tumour necrosis factor related apoptosis inducing ligand–osteoprotegerin (TRAIL–OPG) interaction in rheumatoid arthritis? 176
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 173
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 169
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 169
Potential role of PKC inhibitors in the treatment of hematological malignancies 163
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 160
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 156
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 152
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 150
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 150
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 147
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 145
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 144
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 143
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 134
TRAIL, caspases and maturation of normal and leukemic myeloid precursors 133
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 129
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 124
Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction 120
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis 120
An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction 118
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 104
null 102
Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand 98
null 97
TNF-α modulates the migratory response of mesenchymal stem cells to TRAIL 93
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 91
null 90
null 89
null 88
null 86
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 84
Ruolo di trail nella patogenesi del danno neuronale indotto dalla proteina Tat di HIV-1 84
null 78
null 74
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 72
null 65
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 58
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 47
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL) 36
Totale 6.758
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.545
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021327 0 0 0 0 0 55 15 71 16 66 75 29
2021/2022510 14 53 56 11 15 26 33 25 14 29 64 170
2022/2023457 40 23 17 49 80 78 25 40 47 7 28 23
2023/2024197 16 26 3 5 11 51 9 13 1 3 3 56
2024/2025988 21 32 66 50 144 72 23 47 216 75 143 99
2025/20261.530 281 99 287 344 394 125 0 0 0 0 0 0
Totale 6.758